Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37081608

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2023 Jul 15
First author
Cole KA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Cole KA
      type
      Author
    2. name
      Ijaz H
      type
      Author
    3. name
      Surrey LF
      type
      Author
    4. name
      Santi M
      type
      Author
    5. name
      Liu X
      type
      Author
    6. name
      Minard CG
      type
      Author
    7. name
      Maris JM
      type
      Author
    8. name
      Voss S
      type
      Author
    9. name
      Reid JM
      type
      Author
    10. name
      Fox E
      type
      Author
    11. name
      Weigel BJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Cole KA
      type
      Author
    2. name
      Ijaz H
      type
      Author
    3. name
      Surrey LF
      type
      Author
    4. name
      Santi M
      type
      Author
    5. name
      Liu X
      type
      Author
    6. name
      Minard CG
      type
      Author
    7. name
      Maris JM
      type
      Author
    8. name
      Voss S
      type
      Author
    9. name
      Reid JM
      type
      Author
    10. name
      Fox E
      type
      Author
    11. name
      Weigel BJ
      type
      Author
    bibliography ids
    1. nci-bib-712f70ff0b8126ef2443dab2
    book metadata
    content sha256
    589b1ede8288abdb6663e21a87c187e5686c4cf116dc610134021371037c264e
    document type
    citation
    dois
    1. 10.1002/cncr.34786
    electronic publication date
    display
    2023 Apr 20
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37081608
    immutable id
    pubmed:37081608@589b1ede8288abdb6663e21a87c187e5686c4cf116dc610134021371037c264e
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    14
    name
    Cancer
    nlm unique id
    0374236
    pages
    2245-2255
    volume
    129
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37081608
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      1ec1d7300d3e806633f8cd592e7bad50b32da979f0ae81c9167679d02f282af8
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Jul 15
      precision
      day
      year
      2023
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37081608/
      title
      Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.

      Preserved source evidence · Not medical advice